Patricia Palacios
Overview
Explore the profile of Patricia Palacios including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pernas S, Sanfeliu E, Villacampa G, Salvador J, Perello A, Gonzalez X, et al.
NPJ Breast Cancer
. 2024 Nov;
10(1):101.
PMID: 39592624
With the incorporation of cyclin-dependent kinase inhibitors in early breast cancer (BC), a better identification of biomarkers is needed. The PROMETEO II trial aimed to evaluate the antitumor activity of...
2.
Pereira-Veiga T, Bravo S, Gomez-Tato A, Yanez-Gomez C, Abuin C, Varela V, et al.
Mol Cell Proteomics
. 2024 May;
23(5):100774.
PMID: 38735273
No abstract available.
3.
Pereira-Veiga T, Bravo S, Gomez-Tato A, Yanez-Gomez C, Abuin C, Varela V, et al.
Mol Cell Proteomics
. 2022 Dec;
21(12):100435.
PMID: 36519745
Metastasis is the primary cause of death for most breast cancer (BC) patients who succumb to the disease. During the hematogenous dissemination, circulating tumor cells interact with different blood components....
4.
Rodriguez-Casanova A, Costa-Fraga N, Castro-Carballeira C, Gonzalez-Conde M, Abuin C, Bao-Caamano A, et al.
Front Cell Dev Biol
. 2022 Nov;
10:1016955.
PMID: 36393855
Breast cancers of the luminal B subtype are frequent tumors with high proliferation and poor prognosis. Epigenetic alterations have been found in breast tumors and in biological fluids. We aimed...
5.
6.
Carmona-Ule N, Gonzalez-Conde M, Abuin C, Cueva J, Palacios P, Lopez-Lopez R, et al.
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34071445
Background: Circulating tumor cells (CTC) have relevance as prognostic markers in breast cancer. However, the functional properties of CTCs or their molecular characterization have not been well-studied. Experimental models indicate...
7.
Costa C, Muinelo-Romay L, Cebey-Lopez V, Pereira-Veiga T, Martinez-Pena I, Abreu M, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32365530
Circulating tumor cell (CTC) enumeration has emerged as a powerful biomarker for the assessment of prognosis and the response to treatment in metastatic breast cancer (MBC). Moreover, clinical evidences show...
8.
Abreu M, Cabezas-Sainz P, Pereira-Veiga T, Falo C, Abalo A, Morilla I, et al.
J Clin Med
. 2020 Feb;
9(2).
PMID: 32012729
Traditionally, studies to address the characterization of mechanisms promoting tumor aggressiveness and progression have been focused only on primary tumor analyses, which could provide relevant information but have limitations to...
9.
Pereira-Veiga T, Martinez-Fernandez M, Abuin C, Pineiro R, Cebey V, Cueva J, et al.
Cancers (Basel)
. 2019 Dec;
11(12).
PMID: 31817194
The study of circulating tumor cells (CTCs) has a huge clinical interest in advance and metastatic breast cancer patients. However, many approaches are biased by the use of epithelial markers,...
10.
Albinana V, Gimenez-Gallego G, Garcia-Mato A, Palacios P, Recio-Poveda L, Cuesta A, et al.
TH Open
. 2019 Jul;
3(3):e230-e243.
PMID: 31360828
Hereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia characterized by recurrent and spontaneous epistaxis (nose bleeds), telangiectases on skin and mucosa, internal organ arteriovenous malformations, and dominant autosomal inheritance. Mutations...